Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to Pterygia

Innovative Medical

Overview

To Determine if topical cyclosporine 0.05% BID prevents recurrent inflammation and improves comfort in eyes with pterygia.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Masking

NONE

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * pts with symptomatic pterygia unresponsive to palliative treatment.

Dr. Schechter

Boynton Beach, Florida, United States

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.